Announcements Trials
Browse Landscape

Status

Recruiting 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 16Observational 2

Sponsor

Cancer Type

Genitourinary 2

Conditions

Breast Neoplasms 21Head and Neck Neoplasms 17Prostatic Neoplasms 15Neoplasms 12Lung Neoplasms 12Radiation Injuries 9Esophageal Neoplasms 8Rectal Neoplasms 7Glioma 7Brain Neoplasms 7Glioblastoma 6Carcinoma, Non-Small-Cell Lung 6Uterine Cervical Neoplasms 5Squamous Cell Carcinoma of Head and Neck 5Neoplasm Metastasis 5Carcinoma, Hepatocellular 4Stomach Neoplasms 3Colorectal Neoplasms 3Central Nervous System Neoplasms 3Astrocytoma 3Xerostomia 2Urinary Bladder Neoplasms 2Small Cell Lung Carcinoma 2Sarcoma 2Salivary Gland Neoplasms 2Pelvic Neoplasms 2Osteoradionecrosis 2Lymphedema 2Kidney Neoplasms 2Esthesioneuroblastoma, Olfactory 2

Interventions

Gene Expression Profiling 9Blood Specimen Collection 6Polymerase Chain Reaction 5Immunohistochemistry 5Amplified Fragment Length Polymorphism Analysis 5Surveys and Questionnaires 3Sunitinib 3Reverse Transcriptase Polymerase Chain Reaction 3Flow Cytometry 3Biopsy 3Surgical Procedures, Operative 2Radiotherapy 2Radiosurgery 2Patient Reported Outcome Measures 2Observation 2Nivolumab 2Microarray Analysis 2Immunotherapy 2Genetic Testing 2Drug Therapy 2DNA Methylation 2Cytogenetic Analysis 2tremelimumab 1pembrolizumab 1durvalumab 1atezolizumab 1aldesleukin 1X-Rays 1Watchful Waiting 1Tomography, Optical Coherence 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Observational × Kidney Neoplasms × Radiotherapy × Clear all
NCT06583070 2026-01-28

COSTAR

Peking University First Hospital

Recruiting
300 enrolled
Genitourinary

Carcinoma, Renal Cell, Kidney Neoplasms

NCT06531629 2024-08-06

Risk-based Screen and Prognostic Analysis for Second Primary Malignancies in Kidney Cancer Patients

Peking University First Hospital

Completed
72,408 enrolled
Genitourinary

Kidney Neoplasms, Neoplasms, Second Primary

Data powered by HemOnc (CC BY 4.0) Colophon âš¡